|
1
|
Zheng S, Powell DW, Zheng F, Kantharidis P
and Gnudi L: Diabetic nephropathy: Proteinuria, inflammation, and
fibrosis. J diabetes Res. 2016:52415492016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang S, Li Y, Zhao J, Zhang J and Huang Y:
Mesenchymal stem cells ameliorate podocyte injury and proteinuria
in a type 1 diabetic nephropathy rat model. Biol Blood Marrow
Transplant. 19:538–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yasuda-Yamahara M, Kume S, Tagawa A,
Maegawa H and Uzu T: Emerging role of podocyte autophagy in the
progression of diabetic nephropathy. Autophagy. 11:2385–2386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao L, Wang X, Sun L, Nie H, Liu X, Chen
Z and Guan G: Critical role of serum response factor in podocyte
epithelial-mesenchymal transition of diabetic nephropathy. Diab
Vasc Dis Res. 13:81–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yasuno K, Kamiie J and Shirota K: Analysis
of ultrastructural glomerular basement membrane lesions and
podocytes associated with proteinuria and sclerosis in
osborne-mendel rats with progressive glomerulonephropathy. J Vet
Sci. 14:223–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang L, You YS and Wu W: Role of
CD2-associated protein in podocyte apoptosis and proteinuria
induced by angiotensin II. Ren Fail. 36:1328–1332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tagawa A, Yasuda M, Kume S, Yamahara K,
Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K,
et al: Impaired podocyte autophagy exacerbates proteinuria in
diabetic nephropathy. Diabetes. 65:755–767. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liao R, Liu Q, Zheng Z, Fan J, Peng W,
Kong Q, He H, Yang S, Chen W, Tang X and Yu X: Tacrolimus protects
podocytes from injury in lupus nephritis partly by stabilizing the
cytoskeleton and inhibiting podocyte apoptosis. PloS One.
10:e01327242015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chitra PS, Swathi T, Sahay R, Reddy GB,
Menon RK and Kumar PA: Growth hormone induces transforming growth
factor-beta-induced protein in podocytes: Implications for podocyte
depletion and proteinuria. J Cell Biochem. 116:1947–1956. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ziyadeh FN and Wolf G: Pathogenesis of the
podocytopathy and proteinuria in diabetic glomerulopathy. Curr
Diabetes Rev. 4:39–45. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamaguchi Y, Iwano M, Suzuki D, Nakatani
K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, et al:
Epithelial-mesenchymal transition as a potential explanation for
podocyte depletion in diabetic nephropathy. Am J Kidney Dis.
54:653–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Faul C, Asanuma K, Yanagida-Asanuma E, Kim
K and Mundel P: Actin up: Regulation of podocyte structure and
function by components of the actin cytoskeleton. Trends Cell Biol.
17:428–437. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Kang YS, Dai C, Kiss LP, Wen X and
Liu Y: Epithelial-to-mesenchymal transition is a potential pathway
leading to podocyte dysfunction and proteinuria. Am J Pathol.
172:299–308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pavenstadt H, Kriz W and Kretzler M: Cell
biology of the glomerular podocyte. Physiol Rev. 83:253–307. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Durvasula RV and Shankland SJ: Podocyte
injury and targeting therapy: An update. Curr Opin Nephrol
Hypertens. 15:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang YS, Li Y, Dai C, Kiss LP, Wu C and
Liu Y: Inhibition of integrin-linked kinase blocks podocyte
epithelial-mesenchymal transition and ameliorates proteinuria.
Kidney Int. 78:363–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Susztak K, Raff AC, Schiffer M and
Bottinger EP: Glucose-induced reactive oxygen species cause
apoptosis of podocytes and podocyte depletion at the onset of
diabetic nephropathy. Diabetes. 55:225–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen LH, Liu DW, Chang JL, Chen PR, Hsu
LP, Lin HY, Chou YF, Lee CF, Yang MC, Wen YH, et al: Methylation
status of insulin-like growth factor-binding protein 7 concurs with
the malignance of oral tongue cancer. J Exp Clin Cancer Res.
34:202015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Honore PM, Nguyen HB, Gong M, Chawla LS,
Bagshaw SM, Artigas A, Shi J, Joannes-Boyau O, Vincent JL, Kellum
JA and Sapphire: Topaz Investigators: Urinary tissue inhibitor of
metalloproteinase-2 and insulin-like growth factor-binding protein
7 for risk stratification of acute kidney injury in patients with
sepsis. Crit Care Med. 44:1851–1860. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang J, Chen Z, Liang B, Yan J, Zhang Y,
Xu H, Huang Y and Jiang H: The change of circulating insulin like
growth factor binding protein 7 levels may correlate with
postoperative cognitive dysfunction. Neurosci Lett. 588:125–130.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li N, Zhang Z, Zhang L, Wang S, Zou Z,
Wang G and Wang Y: Insulin-like growth factor binding protein 7, a
member of insulin-like growth factor signal pathway, involved in
immune response of small abalone haliotis diversicolor. Fish
Shellfish Immunol. 33:229–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tamura K, Yoshie M, Hashimoto K and
Tachikawa E: Inhibitory effect of insulin-like growth
factor-binding protein-7 (IGFBP7) on in vitro angiogenesis of
vascular endothelial cells in the rat corpus luteum. J Reprod Dev.
60:447–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan L, Fan WJ, Yang XG, Rao SM, Song JL
and Song GH: Inhibitory effect of exogenous insulin-like growth
factor binding protein 7 on proliferation of human breast cancer
cell line MDA-MB-453 and its mechanism. Sheng Li Xue Bao.
65:519–524. 2013.(In Chinese). PubMed/NCBI
|
|
24
|
Bolomsky A, Hose D, Schreder M, Seckinger
A, Lipp S, Klein B, Heintel D, Ludwig H and Zojer N: Insulin like
growth factor binding protein 7 (IGFBP7) expression is linked to
poor prognosis but may protect from bone disease in multiple
myeloma. J Hematol Oncol. 8:102015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian X, Zhang L, Sun L, Xue Y and Xie S:
Low expression of insulin-like growth factor binding protein 7
associated with poor prognosis in human glioma. J Int Med Res.
42:651–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen D, Siddiq A, Emdad L, Rajasekaran D,
Gredler R, Shen XN, Santhekadur PK, Srivastava J, Robertson CL,
Dmitriev I, et al: Insulin-like growth factor-binding protein-7
(IGFBP7): A promising gene therapeutic for hepatocellular carcinoma
(HCC). Mol Ther. 21:758–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Georges RB, Adwan H, Hamdi H, Hielscher T,
Linnemann U and Berger MR: The insulin-like growth factor binding
proteins 3 and 7 are associated with colorectal cancer and liver
metastasis. Cancer Biol Ther. 12:69–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Z, Tang Y, Hu D and Li J: Inhibitory
effect of genistein on mouse colon cancer MC-26 cells involved
TGF-beta1/Smad pathway. Biochem Biophys Res Commun. 333:827–832.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Satirapoj B and Adler SG: Prevalence and
management of diabetic nephropathy in western countries. Kidney Dis
(Basel). 1:61–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tomino Y and Gohda T: The Prevalence and
management of diabetic nephropathy in asia. Kidney Dis (Basel).
1:52–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L, Su W, Chen H, Chen DQ, Wang M, Guo
Y and Zhao YY: Proteomics for biomarker identification and clinical
application in kidney disease. Adv Clin Chem. 85:91–113. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han Q, Zhang J, Wang Y, Li H, Zhang R, Guo
R, Li L, Teng G, Wang J, Wang T and Liu F: Thyroid hormones and
diabetic nephropathy: An essential relationship to recognize.
Nephrology (Carlton). 2018. View Article : Google Scholar
|
|
34
|
Varga ZV, Giricz Z, Liaudet L, Hasko G,
Ferdinandy P and Pacher P: Interplay of oxidative,
nitrosative/nitrative stress, inflammation, cell death and
autophagy in diabetic cardiomyopathy. Biochim Biophys Acta.
1852:232–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Flyvbjerg A: The role of the complement
system in diabetic nephropathy. Nat Rev Nephrol. 13:311–318. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wada J and Makino H: Inflammation and the
pathogenesis of diabetic nephropathy. Clin Sci (Lond). 124:139–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Imasawa T, Obre E, Bellance N, Lavie J,
Imasawa T, Rigothier C, Delmas Y, Combe C, Lacombe D, Benard G, et
al: High glucose repatterns human podocyte energy metabolism during
differentiation and diabetic nephropathy. FASEB J. 31:294–307.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li JJ, Kwak SJ, Jung DS, Kim JJ, Yoo TH,
Ryu DR, Han SH, Choi HY, Lee JE, Moon SJ, et al: Podocyte biology
in diabetic nephropathy. Kidney Int. Suppl:S36–S42. 2007.
View Article : Google Scholar
|
|
39
|
Zhang Y, Chen Y, Yang F and Zhou J: HBx
transfection limits proliferative capacity of podocytes through
cell cycle regulation. Acta Biochim Biophys Sin (Shanghai).
46:1016–1023. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anders HJ, Vielhauer V and Schlondorff D:
Chemokines and chemokine receptors are involved in the resolution
or progression of renal disease. Kidney Int. 63:401–415. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ferder L, Inserra F and Martinez-Maldonado
M: Inflammation and the metabolic syndrome: Role of angiotensin II
and oxidative stress. Curr Hypertens Rep. 8:191–198. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang Y, Gubler MC and Beaufils H:
Dysregulation of podocyte phenotype in idiopathic collapsing
glomerulopathy and HIV-associated nephropathy. Nephron. 91:416–423.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Madne TH and Dockrell MEC: Human podocytes
responses to alternatively spliced Extra domain A Fibronectin in
culture. Cell Mol Biol (Noisy-le-Grand). 64:45–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rochman M, Travers J, Abonia JP, Caldwell
JM and Rothenberg ME: Synaptopodin is upregulated by IL-13 in
eosinophilic esophagitis and regulates esophageal epithelial cell
motility and barrier integrity. JCI Insight. 2:967892017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen D, Yoo BK, Santhekadur PK, Gredler R,
Bhutia SK, Das SK, Fuller C, Su ZZ, Fisher PB and Sarkar D:
Insulin-like growth factor-binding protein-7 functions as a
potential tumor suppressor in hepatocellular carcinoma. Clin Cancer
Res. 17:6693–6701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Watanabe J, Takiyama Y, Honjyo J, Makino
Y, Fujita Y, Tateno M and Haneda M: Role of IGFBP7 in diabetic
nephropathy: TGF-β1 induces IGFBP7 via smad2/4 in human renal
proximal tubular epithelial cells. PloS One. 11:e01508972016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chang YP, Sun B, Han Z, Han F, Hu SL, Li
XY, Xue M, Yang Y, Chen L, Li CJ and Chen LM: Saxagliptin
attenuates albuminuria by inhibiting podocyte
epithelial-to-mesenchymal transition via sdf-1α in diabetic
nephropathy. Front Pharmacol. 8:7802017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen T, Zheng LY, Xiao W, Gui D, Wang X
and Wang N: Emodin ameliorates high glucose induced-podocyte
epithelial-mesenchymal transition in-vitro and in-vivo. Cell
Physiol Biochem. 35:1425–1436. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Du M, Wang Q, Li W, Ma X, Wu L, Guo F,
Zhao S, Huang F, Wang H and Qin G: Overexpression of FOXO1
ameliorates the podocyte epithelial-mesenchymal transition induced
by high glucose in vitro and in vivo. Biochem Biophys Res Commun.
471:416–422. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen Q, Yang W, Wang X, Li X, Qi S, Zhang
Y and Gao MQ: TGF-β1 induces emt in bovine mammary epithelial cells
through the TGFβ1/smad signaling pathway. Cell Physiol Biochem.
43:82–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ibrini J, Fadel S, Chana RS, Brunskill N,
Wagner B, Johnson TS and El Nahas AM: Albumin-induced epithelial
mesenchymal transformation. Nephron Exp Nephrol. 120:e91–102. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Igietseme JU, Omosun Y, Nagy T, Stuchlik
O, Reed MS, He Q, Partin J, Joseph K, Ellerson D, George Z, et al:
Molecular pathogenesis of chlamydia disease complications:
Epithelial-mesenchymal transition and fibrosis. Infect Immun.
86:e005852017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wiggins RC: The spectrum of
podocytopathies: A unifying view of glomerular diseases. Kidney
Int. 71:1205–1214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yu D, Petermann A, Kunter U, Rong S,
Shankland SJ and Floege J: Urinary podocyte loss is a more specific
marker of ongoing glomerular damage than proteinuria. J Am Soc
Nephrol. 16:1733–1741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kamato D, Burch ML, Piva TJ, Rezaei HB,
Rostam MA, Xu S, Zheng W, Little PJ and Osman N: Transforming
growth factor-beta signalling: role and consequences of Smad linker
region phosphorylation. Cell Signal. 25:2017–2024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ning W, Tao L, Liu C, Sun J, Xiao Y, Hu J,
Chen J, Zheng X and Wang W: Effect of enalapril on the expression
of TGF-beta1, p-Smad2/3 and Smad7 in renal interstitial fibrosis in
rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 34:27–34. 2009.(In
Chinese). PubMed/NCBI
|
